Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea

Sleep and Breathing

Volumn 12, Issue 1, 2008, Pages 53-62

  Roth, Thomas ^a   Rippon, Gregory A ^b   Arora, Sanjay ^b  

^a HENRY FORD HOSPITAL   (United States)

^b CEPHALON INC   (United States)

Author keywords

Armodafinil; Fatigue; Obstructive sleep apnea syndrome; Sleepiness; Wakefulness

Indexed keywords

ARMODAFINIL; PLACEBO;

ADJUVANT THERAPY; ADULT; ANXIETY; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPISODIC MEMORY; FATIGUE; FEMALE; HUMAN; INSOMNIA; LONG TERM MEMORY; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MULTICENTER STUDY; NAUSEA; PATIENT COMPLIANCE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SIDE EFFECT; SLEEP APNEA SYNDROME; SOMNOLENCE; WAKEFULNESS;

ADULT; ATTENTION; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION DISORDERS; COMBINED MODALITY THERAPY; CONTINUOUS POSITIVE AIRWAY PRESSURE; DISORDERS OF EXCESSIVE SOMNOLENCE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; META-ANALYSIS AS TOPIC; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; NEUROPSYCHOLOGICAL TESTS; PSYCHOMETRICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REACTION TIME; RETENTION (PSYCHOLOGY); SLEEP APNEA, OBSTRUCTIVE; WAKEFULNESS;

EID: 38349153331     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-007-0137-7     Document Type: Article

References (46)

1. American Academy of Sleep Medicine (2005) International classification of sleep disorders: Diagnostic and coding manual, 2nd edn. American Academy of Sleep Medicine, Westchester, IL
2. Olson EJ, Moore WR, Morgenthaler TI, Gay PC, Staats BA (2003) Obstructive sleep apnea-hypopnea syndrome. Mayo Clin Proc 78(12):1545-1552
3. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328(17):1230-1235
4. Dincer HE, O'Neill W (2006) Deleterious effects of sleep-disordered breathing on the heart and vascular system. Respiration 73(1):124-130
5. Barbe F, Pericas J, Munoz A, Findley L, Anto JM, Agusti AG (1998) Automobile accidents in patients with sleep apnea syndrome. An epidemiological and mechanistic study. Am J Respir Crit Care Med 158(1):18-22
6. Ulfberg J, Carter N, Edling C (2000) Sleep-disordered breathing and occupational accidents. Scand J Work Environ Health 26(3):237-242
7. Engleman HM, Douglas NJ (2004) Sleep · 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome. Thorax 59(7):618-622
8. Kawahara S, Akashiba T, Akahoshi T, Horie T (2005) Nasal CPAP improves the quality of life and lessens the depressive symptoms in patients with obstructive sleep apnea syndrome. Intern Med 44(5):422-427
9. Sharpe M, Wilks D (2002) Fatigue. BMJ 325(7362):480-483
10. Kushida CA, Littner MR, Hirshkowitz M, Morgenthaler TI, Alessi CA, Bailey D, Boehlecke B, Brown TM, Coleman J Jr, Friedman L, Kapen S, Kapur VK, Kramer M, Lee-Chiong T, Owens J, Pancer JP, Swick TJ, Wise MS; American Academy of Sleep Medicine (2006) Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep 29(3):375-380
11. Giles TL, Lasserson TJ, Smith BJ, White J, Wright J, Cates CJ (2006) Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 1:CD001106
12. Bedard MA, Montplaisir J, Malo J, Richer F, Rouleau I (1993) Persistent neuropsychological deficits and vigilance impairment in sleep apnea syndrome after treatment with continuous positive airways pressure (CPAP). J Clin Exp Neuropsychol 15(2):330-341
13. Morisson F, Decary A, Petit D, Lavigne G, Malo J, Montplaisir J (2001) Daytime sleepiness and EEG spectral analysis in apneic patients before and after treatment with continuous positive airway pressure. Chest 119(1):45-52
14. Sforza E, Krieger J (1992) Daytime sleepiness after long-term continuous positive airway pressure (CPAP) treatment in obstructive sleep apnea syndrome. J Neurol Sci 110:21-26
15. Ferini-Strambi L, Baietto C, Di Gioia MR, Castaldi P, Castronovo C, Zucconi M, Cappa SF (2003) Cognitive dysfunction in patients with obstructive sleep apnea (OSA): Partial reversibility after continuous positive airway pressure (CPAP). Brain Res Bull 61(1):87-92
16. Kotterba S, Rasche K, Widdig W, Duscha C, Blombach S, Schultze-Werninghaus G, Malin JP (1998) Neuropsychological investigations and event-related potentials in obstructive sleep apnea syndrome before and during CPAP-therapy. J Neurol Sci 159(1):45-50
17. Naegele B, Thouvard V, Pepin JL, Levy P, Bonnet C, Perret JE, Pellat J, Feuerstein C (1995) Deficits of cognitive executive functions in patients with sleep apnea syndrome. Sleep 18(1):43-52
18. Weaver TE, Maislin G, Dinges DF, Bloxham T, George CFP, Greenberg H, Kader G, Mahowald M, Younger J, Pack AI (2007) Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep 30(6):711-719
19. Black JE, Hirshkowitz M (2005) Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome. Sleep 28(4):464-471
20. Pack AI, Black JE, Schwartz JR, Matheson JK (2001) Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. Am J Respir Crit Care Med 164(9):1675-1681
21. Wong YN, King SP, Simcoe D, Gorman S, Laughton W, McCormick GC, Grebow P (1999) Open-label, single-dose pharmacokinetic study of modafinil tablets: Influence of age and gender in normal subjects. J Clin Pharmacol 39(3):281-288
22. Wong YN, Simcoe D, Hartman LN, Gorman S, Laughton W, McCormick GC, Grebow P (1999) A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers. J Clin Pharmacol 39(1):30-40
23. Robertson P Jr, Hellriegel ET (2003) Clinical pharmacokinetic profile of modafinil. Clin Pharmacokinet 42(2):123-137
24. Dinges DF, Arora S, Darwish M, Niebler GE (2006) Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss. Curr Med Res Opin 22(1):159-167
25. Harsh J, Hayduk R, Rosenberg R, Wesnes KA, Walsh JK, Arora S, Niebler GE, Roth T (2006) The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy. Curr Med Res Opin 22(4):761-774
26. Hirshkowitz M, Black JE, Wesnes K, Niebler G, Arora S, Roth T (2007) Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome. Respir Med 101(3):616-627
27. Roth T, White D, Schmidt-Nowara W, Wesnes KA, Niebler G, Arora S, Black J (2006) Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: A 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults. Clin Ther 28(5):689-706
28. US Department of Health and Human Services (1996) Guidance for industry. E6 good clinical practice: Consolidated guidance. US Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Rockville, MD
29. Guy W (1976) Clinical Global Impressions. ECDEU assessment manual for psychopharmacology. US Dept of Health and Human Services, National Institute of Mental Health, Rockville, MD, pp 218-222
30. Johns MW (1991) A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep 14(6):540-545
31. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC
32. Poceta JS, Timms RM, Jeong DU, Ho SL, Erman MK, Mitler MM (1992) Maintenance of wakefulness test in obstructive sleep apnea syndrome. Chest 101(4):893-897
33. Doghramji K, Mitler MM, Sangal RB, Shapiro C, Taylor S, Walsleben J, Belisle C, Erman MK, Hayduk R, Hosn R, O'Malley EB, Sangal JM, Schutte SL, Youakim JM (1997) A normative study of the Maintenance of Wakefulness Test (MWT). Electroencephalogr Clin Neurophysiol 103(5):554-562
34. Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. UCLA Brain Information Service/Brain Research Institute, Los Angeles, CA
35. Keith MS, Stanislav SW, Wesnes KA (1998) Validity of a cognitive computerized assessment system in brain-injured patients. Brain Inj 12(12):1037-1043
36. Wesnes KA, McKeith IG, Ferrara R, Emre M, Del Ser T, Spano PF, Cicin-Sain A, Anand R, Spiegel R (2002) Effects of rivastigmine on cognitive function in dementia with Lewy bodies: A randomised placebo-controlled international study using the Cognitive Drug Research computerised assessment system. Dement Geriatr Cogn Disord 13(3):183-192
37. Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, Huber SL (1999) The rapid assessment of fatigue severity in cancer patients: Use of the Brief Fatigue Inventory. Cancer 85(5):1186-1196
38. Arand D, Bonnet M, Hurwitz T, Mitler M, Rosa R, Sangal RB (2005) The clinical use of the MSLT and MWT. Sleep 28(1):123-144
39. Bartlett DJ, Rae C, Thompson CH, Byth K, Joffe DA, Enright T, Grunstein RR (2004) Hippocampal area metabolites relate to severity and cognitive function in obstructive sleep apnea. Sleep Med 5:593-596
40. Sateia MJ (2003) Neuropsychological impairment and quality of life in obstructive sleep apnea. Clin Chest Med 24(2):249-259
41. Thomas RJ, Rosen BR, Stern CE, Weiss JW, Kwong KK (2005) Functional imaging of working memory in obstructive sleep-disordered breathing. J Appl Physiol 98(6):2226-2234
42. Barnes M, Houston D, Worsnop CJ, Neill AM, Mykytyn IJ, Kay A, Trinder J, Saunders NA, Douglas McEvoy R, Pierce RJ (2002) A randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. Am J Respir Crit Care Med 165(6):773-780
43. Engleman HM, Martin SE, Kingshott RN, Mackay TW, Deary IJ, Douglas NJ (1998) Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/ hypopnoea syndrome. Thorax 53(5):341-345
44. Shen J, Barbera J, Shapiro CM (2006) Distinguishing sleepiness and fatigue: Focus on definition and measurement. Sleep Med Rev 10(1):63-76
45. Lichstein KL, Means MK, Noe SL, Aguillard RN (1997) Fatigue and sleep disorders. Behav Res Ther 35(8):733-740
46. Hossain JL, Reinish LW, Kayumov L, Bhuiya P, Shapiro CM (2003) Underlying sleep pathology may cause chronic high fatigue in shift-workers. J Sleep Res 12(3):223-230